Fig. 5
From: Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer
The ROC curve analyses using CPT1A, CA15–3, CEA and CA125 for the differentiation of breast cancer cases and healthy controls. a ROC curves of CPT1A, CA15–3, CEA and CA125 for breast cancer cases versus healthy controls in the training set (left) and test set (right), respectively. b ROC curves of CPT1A and a model which combined the analysis of CPT1A, CA15–3, CEA and CA125 for breast cancer cases versus healthy controls in the training set (left) and test set (right), respectively